Audiovisual Assessment After Dural Puncture During Epidural Placement in Obstetric Patients

The study involves assessment of hearing and visual complications along with headache after accidental dural puncture in patients receiving epidurals. Hearing loss will be assessed by clinical examination and audiometry testing, while visual complications will be assessed by clinical examination. The patients will receive standard treatment for headache in the form of drugs and if required an epidural blood patch ( injecting patient's blood in the epidural space). The course of these complications and response to treatment will be investigated over a period of time.

Audiometry results from patients with dural puncture will be compared to those of patients who also had epidurals, but without a dural puncture.

The investigators hypothesize that audiovisual complications occur more frequently in patients having accidental dural puncture with epidural needle and that the symptoms resolve with the administration of epidural blood patch.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Although many studies have reported auditory complications after spinal, none have been done in obstetric patients with accidental dural puncture with epidural needle. Long term follow up of these complications has been unknown. The incidence of both auditory and visual complications is likely to be high in patients getting accidental dural puncture with 17G Touhy epidural needle as compared to small gauge spinal needles. Several case reports have been reported with such temporary and permanent hearing and visual loss. A prospective study to understand these complications is required. The study will provide us with the true incidence of audiovisual complications of dural puncture with an epidural needle. Early intervention in cases of dural puncture may alleviate or halt symptoms.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Toronto, Ontario, Canada, M5G1X5
        • Mount Sinai Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women having epidural analgesia for labour pain management.

Description

Inclusion Criteria:

  • Parturients having accidental dural puncture during epidural placement for labour analgesia.
  • Patients who give written informed consent to participate in the study.
  • Dural puncture with 17G Touhy needle with/out headache
  • Postural headache after 24 hours of epidural
  • Labouring women undergoing vaginal or Cesarean delivery
  • For the control group, patients with no dural puncture during epidural placement

Exclusion criteria:

  • Patients refusing to consent
  • Dural puncture with spinal needle

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Patients with dural puncture at epidural
Patients who sustained an accidental dural puncture during the epidural procedure.
Other Names:
  • hearing test
Patients with no dural puncture
Patients with no dural puncture during epidural procedure, to serve as a control group.
Other Names:
  • hearing test

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Hearing loss
Time Frame: 1 month
Hearing loss as measured by audiometry
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Severity of headache
Time Frame: 1 month
Pain from postdural puncture headache, rated on verbal numeric rating scale (VNRS) from 0-10, where 0 represents no pain and 10 represents worst pain.
1 month
Associated vestibular symptoms
Time Frame: 1 month
The presence of nausea, vomiting, vertigo, dizziness, associated with the dural puncture headache.
1 month
Associated cochlear symptoms
Time Frame: 1 month
The presence of hearing loss, hyperacusis or tinnitus, associated with the dural puncture headache.
1 month
Ocular symptoms
Time Frame: 1 month
The presence of photophobia, teichopsia, diplopia or difficulty in accommodation, associated with the dural puncture headache.
1 month
Musculoskeletal symptoms
Time Frame: 1 month
The presence of neck stiffness or scapular pain, associated with the dural puncture headache.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 25, 2007

Primary Completion (ACTUAL)

February 18, 2010

Study Completion (ACTUAL)

April 30, 2010

Study Registration Dates

First Submitted

February 5, 2018

First Submitted That Met QC Criteria

February 5, 2018

First Posted (ACTUAL)

February 12, 2018

Study Record Updates

Last Update Posted (ACTUAL)

February 14, 2018

Last Update Submitted That Met QC Criteria

February 12, 2018

Last Verified

February 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hearing Loss

Clinical Trials on Audiometry

3
Subscribe